- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 942
Oncology Analytics processes $21m series B
McKesson Ventures and returning investor BlueCross BlueShield Venture Partners took part in a round that will support the cancer data provider's technology capabilities.
Nov 7, 2018Molekule follows investors to $25m series B
Molekule, developer of a molecular-level air purifier, took its total funding to $39m in a Foundry Group-led round that did not include existing investor Foxconn.
Nov 7, 2018Ambiq Micro ambles to $29m
The Arm and Fujitsu-backed low-power chip producer has now raised more than $135m altogether, after securing $29.1m from investors including EDBI.
Nov 7, 2018Shape Security locks up $26m
JetBlue Technology Ventures and Singtel Innov8 have become cybersecurity software provider Shape's latest corporate backers, joining GV and HPE Pathfinder.
Nov 7, 2018Vitamica energises seed round
Bristol spinout Vitamica has closed a seed round with the backing of University of Bristol Enterprise Fund II and Wyvern Seed Fund.
Nov 7, 2018Tink Labs aims for $300m result
Hotel smartphone provider Tink Labs already counts Foxconn and TCL as investors but has reportedly approached travel and hospitality companies for funding at a $1.5bn valuation.
Nov 6, 2018Dynamic Yield regenerates with $38m series D
Naver has joined Dynamic Yield’s series D round, which now totals $38m, three months after Union Group contributed to its initial close.
Nov 6, 2018Opera shoots for StarMaker with $30m
Opera has injected $30m into entertainment-focused social media company StarMaker and secured an option to acquire a majority stake in 2020.
Nov 6, 2018Hypothermia Devices fulfils $10.7m hype
UCLA spinout Hypothermia Devices graduated from a university-based accelerator in February and is now commercialising body temperature management devices for the medical and athletics markets.
Nov 6, 2018Omeicos completes series C operation
Returning investor SMS Group took part in a $19.5m round for Omeicos that will fund the entry of its persistent atrial fibrillation drug candidate into a phase 2 trial.
Nov 6, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


